ATE45672T1 - Eine pharmazeutische zusammensetzung zum zweck der behandlung einer neurologischen krankheit oder des alterns. - Google Patents

Eine pharmazeutische zusammensetzung zum zweck der behandlung einer neurologischen krankheit oder des alterns.

Info

Publication number
ATE45672T1
ATE45672T1 AT84303195T AT84303195T ATE45672T1 AT E45672 T1 ATE45672 T1 AT E45672T1 AT 84303195 T AT84303195 T AT 84303195T AT 84303195 T AT84303195 T AT 84303195T AT E45672 T1 ATE45672 T1 AT E45672T1
Authority
AT
Austria
Prior art keywords
aging
pharmaceutical composition
neurological disease
treatment
choline
Prior art date
Application number
AT84303195T
Other languages
English (en)
Inventor
Richard J Wurtman
Original Assignee
Massachusetts Inst Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Massachusetts Inst Technology filed Critical Massachusetts Inst Technology
Application granted granted Critical
Publication of ATE45672T1 publication Critical patent/ATE45672T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT84303195T 1983-05-16 1984-05-11 Eine pharmazeutische zusammensetzung zum zweck der behandlung einer neurologischen krankheit oder des alterns. ATE45672T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US49520283A 1983-05-16 1983-05-16
EP84303195A EP0125900B1 (de) 1983-05-16 1984-05-11 Eine pharmazeutische Zusammensetzung zum Zweck der Behandlung einer neurologischen Krankheit oder des Alterns

Publications (1)

Publication Number Publication Date
ATE45672T1 true ATE45672T1 (de) 1989-09-15

Family

ID=23967687

Family Applications (1)

Application Number Title Priority Date Filing Date
AT84303195T ATE45672T1 (de) 1983-05-16 1984-05-11 Eine pharmazeutische zusammensetzung zum zweck der behandlung einer neurologischen krankheit oder des alterns.

Country Status (8)

Country Link
EP (1) EP0125900B1 (de)
JP (1) JPS60214734A (de)
AT (1) ATE45672T1 (de)
CA (1) CA1228301A (de)
DE (1) DE3479477D1 (de)
ES (1) ES8602409A1 (de)
GR (1) GR79973B (de)
IL (1) IL71819A (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2657013B1 (fr) * 1990-01-18 1992-05-15 Medgenix Group Sa Composition dietetique a base de polypeptides et acides amines.

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1114295A (en) * 1977-11-02 1981-12-15 John H. Growdon Process and composition for treating disorders by administering choline or a compound that dissociates to choline
DE2962429D1 (en) * 1978-04-24 1982-05-19 Massachusetts Inst Technology A pharmaceutical composition comprising an amino acid for reducing blood serum prolactin levels
DE2967257D1 (en) * 1978-04-24 1984-11-22 Massachusetts Inst Technology Composition for regulating dopamine or norepinephrine levels in neuronal synapses
US4296119A (en) * 1978-04-24 1981-10-20 Massachusetts Institute Of Technology Process and composition for reducing blood pressure in animals
JPS5566512A (en) * 1978-11-15 1980-05-20 Massachusetts Inst Technology Method and composition for treating difficulties by administration of choline or choline dissociating compound
US4221784A (en) * 1979-04-05 1980-09-09 Massachusetts Institute Of Technology Process and composition for treating disorders by administering lecithin
DE2915433A1 (de) * 1979-04-17 1980-10-30 Christensen Plantorgan Werk Verwendung von physiologisch vertraeglichen methyldonatoren
US4397866A (en) * 1979-05-07 1983-08-09 Massachusetts Institute Of Technology Process for increasing glycine levels in the brain and spinal cord

Also Published As

Publication number Publication date
DE3479477D1 (en) 1989-09-28
GR79973B (de) 1984-10-31
ES532873A0 (es) 1985-12-16
JPS60214734A (ja) 1985-10-28
IL71819A0 (en) 1984-09-30
EP0125900B1 (de) 1989-08-23
JPH0141124B2 (de) 1989-09-04
IL71819A (en) 1987-12-31
CA1228301A (en) 1987-10-20
ES8602409A1 (es) 1985-12-16
EP0125900A1 (de) 1984-11-21

Similar Documents

Publication Publication Date Title
ATE113834T1 (de) Zusammensetzung zur behandlung der schizophrenie.
DE69132688D1 (de) Methode zur behandlung und vorbeugung von typ-1 diabetis durch orale verabreichung von insulin
DK46789D0 (da) 3-indolpyrodruesyrederivater og farmaceutisk anvendelse deraf
DE3684190D1 (de) Verwendung von tetrahydrobiopterinen zur herstellung eines medikaments zur behandlung von kinderautismus.
DE69230046D1 (de) 2-Bromomelatonin zur Behandlung von Schlafstörungen
DE3856594D1 (de) Mittel zur behandlung der alzheimer-krankheit
DE3752112D1 (de) Verwendung von Inositoltriphosphat zur Behandlung von Entzündungen
ATE110958T1 (de) Verwendung von sertralin zur behandlung verfrühter ejakulation.
DE69009684D1 (de) Pharmazeutische Zusammensetzungen zur Behandlung gastrointestinaler Störungen.
ATE107515T1 (de) Zusammensetzung zur behandlung von entzündung.
DK0502925T3 (da) præparat til behandling af inflammatoriske tarmlidelser
DE3583887D1 (de) Ausruestung fuer die behandlung der osteoporose.
DE69228949D1 (de) Tgf-beta zur verbesserung der regeneration von neuronalem gewebe
IT1170214B (it) Composizione farmaceutica per la cura delle arteriopatie periferiche
DE69316013D1 (de) Verwendung von phosphinate zur behandlung der osteoporose
FI864246A (fi) N-substituerade 3-piperidin- eller 3-pyridinkarboxylsyror samt deras derivat.
ATE45672T1 (de) Eine pharmazeutische zusammensetzung zum zweck der behandlung einer neurologischen krankheit oder des alterns.
ATE87482T1 (de) Pharmazeutische praeparate zur behandlung von zereberalen psycho-organischen syndromen.
DE3775854D1 (de) Arzneimittel zur therapie von durch funktionelle und organische basen verursachten gehirnkrankheiten.
PT98764A (pt) Processo para a preparacao de composicoes contendo factor de desenvolvimento de insulina 1 completo para o tratamento terapeutico ou profilactico de estado catabolicos
DE3878154D1 (de) Oral anzuwendende arzneiform zur einmal taeglichen behandlung der hypertonie mit diltiazemhydrochlorid.
DE3476736D1 (en) Use of an antihypoxidoticum with cerebral and peripheral effect
DE69118847D1 (de) Verwendung von Heptastigmin zur Behandlung der zerebralen Ictus
RU94038232A (ru) Средство, улучшающее мозговое кровообращение
DE3786442D1 (de) Verwendung von follikelreifungshormon zur herstellung eines therapeutischen mittels zur behandlung von neoplasmen von gonadalem ursprung.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee